Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Clinical trial NCT06934252 · RECRUITING

Trial details

NCT number: NCT06934252
Sponsor: TRex Bio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate-to-severe Atopic Dermatitis

Start date: 2025-05-02
Primary completion: 2027-09-02
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.